Position in ABBV
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$19,393,139
+$2,184,026 QoQ
Shares Held
77,067
-2.6% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
2.05%
of 13F equity value
Holder Rank
#623
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AMERICAN NATIONAL BANK & TRUST holds $79,015,646 across 10 Drug Manufacturers - General names. ABBV ranks #2 (24.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
90,625 | $23,016,031 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
77,067 | $19,393,139 | |
| 3 | LLY |
ELI LILLY & Co
|
15,875 | $19,040,952 | |
| 4 | AMGN |
Amgen Inc
|
34,999 | $12,673,837 | |
| 5 | MRK |
Merck & Co., Inc.
|
26,998 | $3,469,243 | |
| 6 | PFE |
Pfizer Inc
|
22,270 | $536,261 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,578 | $452,044 | |
| 8 | NVS |
Novartis AG
|
1,786 | $279,901 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,393,139 | 77,067 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $17,209,113 | 79,126 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $18,106,690 | 79,245 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $18,245,815 | 78,802 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $14,973,037 | 80,665 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $16,414,844 | 78,345 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $14,621,333 | 82,281 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $12,784,065 | 64,736 | Shares | Sole | 2024-10-02 | |
| 2024-06-30 | $12,044,305 | 70,221 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $11,145,976 | 61,208 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $9,203,978 | 59,392 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $8,451,254 | 56,697 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $7,306,407 | 54,230 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $7,702,033 | 48,328 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $7,435,514 | 46,009 | Shares | Sole | 2023-01-10 | |
| 2022-09-30 | $6,250,428 | 46,572 | Shares | Sole | 2022-10-05 | |
| 2022-06-30 | $7,256,414 | 47,378 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $9,517,964 | 58,713 | Shares | Sole | 2022-04-08 | |
| 2021-12-31 | $7,923,608 | 58,520 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $6,467,453 | 59,956 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $5,811,773 | 51,596 | Shares | Sole | 2021-07-12 | |
| 2021-03-31 | $6,036,403 | 55,779 | Shares | Sole | 2021-04-09 | |
| 2020-12-31 | $4,362,183 | 40,711 | Shares | Sole | 2021-01-06 | |
| 2020-09-30 | $216,785 | 2,475 | Shares | Sole | 2020-10-06 | |
| 2020-06-30 | $186,051 | 1,895 | Shares | Sole | 2020-07-07 | |
| 2020-03-31 | $91,428 | 1,200 | Shares | Sole | 2020-04-06 | |
| No filing history on record for this holder in this stock. | ||||||